The Infectious Diseases Society of America (IDSA) offered criteria for testing inpatients and outpatients for COVID-19, while ACP addressed what communities need in order to safely resume economic activities and in-person medical visits.
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies showed.
The American Thoracic Society addresses potential use of hydroxychloroquine for patients with COVID-19 and pneumonia, and two case series reports describe use of convalescent plasma in critically ill patients with COVID-19 in China.
Dr. Auron. Just over 100 years later, a novel coronavirus was identified.
Trials have found some potential benefit from remdesivir, early treatment with methylprednisolone, and measurement of C-reactive protein. Early vaccine trial results and guidance on antibody testing were also recently released.
Recent articles offered advice on avoiding overuse in medicine and viral spread, including during ventilation. A study found mood problems and fears among physicians treating COVID-19, while mental health experts offered some solutions.
The Infectious Diseases Society of America releases guidance on infection prevention, hospitalists look at how to maintain their own health and physical distancing during the pandemic, and experts highlight ethical problems with policies on
Two studies report outcomes of patients hospitalized in the U.S., the CDC focuses on incidence among the homeless, and the FDA warns about antibody testing.
Lactate dehydrogenase and other biomarkers appear to predict risk of critical illness and death, and testing soon after exposure is associated with high rates of false negatives, new studies showed.
ACP provided resources on telehealth and physician well-being, while cardiology groups advised patients to stay on angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers.